IvorBenjaminMD

Obstetrics & Gynecology • Avondale, AZ

Gynecologic Oncology

Arizona Center for Cancer Care

Join to view full profile

Dr. Benjamin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Benjamin's full profile

Already have an account?

Office
10320 W McDowell Rd Bldg H #8025
Avondale, AZ 85392
Phone+1 623-238-7330
Is this information wrong?

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Gynecologic Oncology, 1991 - 1994
University of Pennsylvania Health SystemResidency, Obstetrics and Gynecology, 1987 - 1991
Columbia University Vagelos College of Physicians and SurgeonsClass of 1987

Certifications & Licensure

AZ State Medical License 2008 - 2025
NM State Medical License 2011 - 2011
PA State Medical License 1988 - 2002
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Clinical Trials

Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
Completed
Phase 3
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
Active, not recruiting
Phase 3
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Start of enrollment: 2009 Jun 29
Active, not recruiting
Phase 3
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer Start of enrollment: 2009 Aug 17
Active, not recruiting
Phase 3
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 2
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma Start of enrollment: 2009 Nov 01
Terminated
Phase 3
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer Start of enrollment: 2010 Oct 12
Active, not recruiting
Phase 3
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer Start of enrollment: 2010 Aug 01
Completed
Phase 2
Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer Start of enrollment: 2011 Apr 04
Completed
Phase 2
Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Start of enrollment: 2011 Aug 15
Active, not recruiting
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

In vitro chemoresponse in metachronous pairs of ovarian cancers.
Dalton, H. J.,Fiorica, J. V.,Edwards, R. P.,Benjamin, I.,Rocconi, R. P.,Recio, F. O.,Lovecchio, J. L.,Burrell, M. O.,Shahin, M. S.,Grendys, E. C.,Wang, D.,Wang, T.,Mon...> ;Anticancer Res.. 2014 Dec 17
32 citations
Antiangiogenic agents as a maintenance strategy for advanced epithelial ovarian cancer
Bradley J. Monk, Heather J. Dalton, John H. Farley, Dana M. Chase, Ivor Benjamin> ;Critical Reviews in Oncology/hematology. 2013 May 1
17 citations
Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer
Bradley J. Monk, Heather J. Dalton, Ivor Benjamin, Adnan Tanovic> ;Current Pharmaceutical Design. 2012 Jul 31
An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancer.
Dalton HJ, Yu X, Hu L, Kapp DS, Benjamin I, Monk BJ, Chan JK> ;Gynecol. Oncol.. 2012-02-01
Acquired drug resistance in gynecologic cancer detected by drug response marker testing.
Benjamin I, Dalton HJ, Monk BJ> ;J. Clin. Oncol.. 2011-05-20
Endometrial cancer surgery in Arizona: a statewide analysis of access to care.
Benjamin, I.,Dalton, H.,Qiu, Y.,Cayco, L.,Johnson, W. G.,Balducci, J.> ;Gynecol. Oncol.. 2011 Jan 07
157 citations
Detection of Hypoxia in Human Squamous Cell Carcinoma by EF5 Binding
Sydney M. Evans, Stephen M. Hahn, Deirdre R. Pook, W. Timothy Jenkins, Ara A. Chalian, Paul J. Zhang, Craig W. Stevens, R.S. Weber, Gregory S. Weinstein, Ivor Benjamin...> ;Cancer Research. 2000 Apr 1
Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitonea...
Coukos G, Makrigiannakis A, Montas S, Kaiser LR, Toyozumi T, Benjamin I, Albelda SM, Rubin SC, Molnar-Kimber KL> ;Cancer Gene Ther.. 2000-02-01
Complete hydatidiform mole. A disease with a changing profile.
Coukos G, Makrigiannakis A, Chung J, Randall TC, Rubin SC, Benjamin I> ;J Reprod Med. 1999-08-01
Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer.
Coukos G, Makrigiannakis A, Kang EH, Caparelli D, Benjamin I, Kaiser LR, Rubin SC, Albelda SM, Molnar-Kimber KL> ;Clin. Cancer Res.. 1999-06-01
Occult bilateral involvement in stage I epithelial ovarian cancer.
Benjamin I, Morgan MA, Rubin SC> ;Gynecol. Oncol.. 1999-03-01
Sutureless technique for cold-knife conization: a report of seventy-four consecutive cases.
Benjamin I, Segel SY, Rubin SC> ;J Low Genit Tract Dis. 1999-01-01
Allelotype analysis of uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q.
van der Heijden O, Chiu HC, Park TC, Takahashi H, LiVolsi VA, Risinger JI, Barrett JC, Berchuck A, Evans AC, Behbakht K, Menzin AW, Liu PC, Benjamin I, Morgan MA, King...> ;Mol. Carcinog.. 1998-12-01
Clinical characteristics of clear cell carcinoma of the ovary.
Behbakht K, Randall TC, Benjamin I, Morgan MA, King S, Rubin SC> ;Gynecol. Oncol.. 1998-08-01
1 citations
Oncology and the Internet.
Ivor Benjamin, Goldwein Jw> ;M.D. Computing. 1998 Jul 1
BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications ...
Rubin SC, Blackwood MA, Bandera C, Behbakht K, Benjamin I, Rebbeck TR, Boyd J> ;Am. J. Obstet. Gynecol.. 1998-04-01
Endometrial adenocarcinoma with trophoblastic differentiation.
Bradley CS, Benjamin I, Wheeler JE, Rubin SC> ;Gynecol. Oncol.. 1998-04-01
Modern treatment options in epithelial ovarian carcinoma.
Benjamin I, Rubin SC> ;Curr. Opin. Obstet. Gynecol.. 1998-02-01
Advances in cytoreductive surgery of gynecologic cancers.
Benjamin I, Rubin SC> ;Cancer Treat. Res.. 1998-01-01
Cycles of dose-intensive chemotherapy with peripheral stem cell support in persistent or recurrent platinum-sensitive ovarian cancer.
Morgan MA, Stadtmauer EA, Luger SM, Porter DL, Mangan PA, O'Neil P, Kamelle S, Benjamin I, Mick R, King SA, Rubin SC> ;Gynecol. Oncol.. 1997-12-01
2 citations
Administration of a World Wide Web site during a period of rapid growth: the OncoLink experience
Ivor Benjamin, T. J. Dilling, J. W. Goldwein> ;M.D. Computing. 1997 Sep 1
28 citations
Postoperative day 1 serum human chorionic gonadotropin level as a predictor of persistent ectopic pregnancy after conservative surgical management
Steven D. Spandorfer, Stephen W. Sawin, Ivor Benjamin, Kurt T. Barnhart> ;Fertility and Sterility. 1997 Sep 1
Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma.
Bandera CA, Takahashi H, Behbakht K, Liu PC, LiVolsi VA, Benjamin I, Morgan MA, King SA, Rubin SC, Boyd J> ;Cancer Res.. 1997-02-01
Initial surgical management of advanced epithelial ovarian cancer.
Benjamin I, Rubin SC> ;Cancer Invest.. 1997-01-01
Effect of surgical debulking on survival in stage IV ovarian cancer.
Liu PC, Benjamin I, Morgan MA, King SA, Mikuta JJ, Rubin SC> ;Gynecol. Oncol.. 1997-01-01
Join now to see all

Hospital Affiliations

St. Joseph's Hospital and Medical CenterPhoenix, Arizona
HonorHealth Scottsdale Osborn Medical CenterScottsdale, Arizona
HonorHealth Scottsdale Shea Medical CenterScottsdale, Arizona
HonorHealth Deer Valley Medical CenterPhoenix, Arizona

IvorBenjaminMD

Dr. Benjamin is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.